Select language:  
1800 620 420
Close menu

Translational Research Program

Translational Research Program

The Translational Research Program (TRP) takes a bench-to-bedside focus, with a view to accelerating laboratory findings into actual blood cancer treatments.

The Leukaemia Foundation joins USA’s Leukemia and Lymphoma Society and the Snowdome Foundation in this international research collaboration to jointly fund of up to two TRP applications focused on blood cancer research from investigators working in Australia, Australian investigators working in other countries, or to Australian and non-Australian researchers jointly applying.

As an LLS initiative, this program funds new and innovative research that proposes novel approaches to the prevention, diagnosis, or treatment of blood cancers and shows high promise for translating basic biomedical knowledge to clinical application.

Proposals should be based on molecular, cellular, or integrated systems findings and be conceptually innovative.

Funding applications for 2023 are scheduled to open in August 2022.  Please monitor the LLS website for updates to the application timeline.

Meet previous TRP recipients 


Leukaemia and lymphoma society logo